EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY-NC 4.0

Accuracy of the Montreal Cognitive Assessment tool for detecting mild cognitive impairment: A systematic review and meta‐analysis

Nayaar Islam iD, Rola Hashem, Maryse Gad, Aime Brown, Brooke Levis, Christel Renoux, Brett D Thombs, Matthew Df McInnes

Alzheimer's & Dementia · 2023-07 · 19 (7) · 3235-3243

DOI: 10.1002/alz.13040 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Alzheimer's & Dementia, online erschienen am 19.03.2023. Verfasst von Nayaar Islam und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Canada. Hauptthemen laut MEDLINE: Cognitive Dysfunction. Die Arbeit wurde bisher 227-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION This systematic review evaluates the accuracy of the Montreal Cognitive Assessment (MoCA) for detecting mild cognitive impairment (MCI). METHODS We searched MEDLINE, PSYCInfo, EMBASE, and Cochrane CENTRAL (1995–2021) for studies comparing the MoCA with validated diagnostic criteria to identify MCI in general practice. Screening, data extraction, and risk of bias assessment were performed independently, in duplicate. Pooled sensitivity and specificity for MoCA cutoffs were estimated using bivariate meta‐analysis. RESULTS Thirteen studies [2158 participants, 948(44%) with MCI] were included; 10 used Petersen criteria as the reference standard. Risk of bias of studies were high or unclear for all domains except reference standard. Sensitivity and specificity were 73.5%(95% confidence interval: 56.7–85.5) and 91.3%(84.6–95.3) at cutoff

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionHumansMental Status and Dementia TestsSensitivity and SpecificityNeurologic ExaminationNeuropsychological Tests

Stichwörter der Autor:innen

Montreal Cognitive Assessment toolaccuracymild cognitive impairmentmild neurocognitive disorderscreening

Autor:innen und Institutionen

  • School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Canada.
  • Centre for Prognosis Research, School of Medicine, Keele University, Newcastle, UK.
  • Lady Davis Institute for Medical Research, Jewish General Hospital, and McGill University, Montreal, Quebec, Canada.
  • Department of Radiology, University of Ottawa, Ottawa, Canada.
  • Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.

ORCID-Profile: Nayaar Islam

Zitieren

APA

Islam, N., Hashem, R., Gad, M., Brown, A., Levis, B., Renoux, C., Thombs, B. D., & McInnes, M. D. (2023). Accuracy of the Montreal Cognitive Assessment tool for detecting mild cognitive impairment: A systematic review and meta‐analysis. Alzheimer's & Dementia, 19(7), 3235-3243. https://doi.org/10.1002/alz.13040

Vancouver

Islam N, Hashem R, Gad M, Brown A, Levis B, Renoux C, et al. Accuracy of the Montreal Cognitive Assessment tool for detecting mild cognitive impairment: A systematic review and meta‐analysis. Alzheimer's & Dementia. 2023;19(7):3235-3243. doi:10.1002/alz.13040

BibTeX
@article{Islam2023,
  author = {Islam, Nayaar and Hashem, Rola and Gad, Maryse and Brown, Aime and Levis, Brooke and Renoux, Christel and Thombs, Brett D and McInnes, Matthew Df},
  title = {Accuracy of the Montreal Cognitive Assessment tool for detecting mild cognitive impairment: A systematic review and meta‐analysis},
  journal = {Alzheimer's & Dementia},
  year = {2023},
  volume = {19},
  number = {7},
  pages = {3235--3243},
  doi = {10.1002/alz.13040}
}
Kostenlos starten →